Latest news with #Havix

Business Upturn

Senores Pharma's subsidiary Havix completes USFDA inspection with 3 observations

Senores Pharmaceuticals announced that its material subsidiary, Havix Group Inc. (doing business as Aavis Pharmaceuticals), successfully completed a routine inspection by the U.S. Food and Drug Administration (USFDA). The inspection was conducted at Havix's manufacturing facility located at 9488 Jackson Trail Road, Hoschton, Georgia, USA, from July 21 to July 25, 2025. The USFDA issued three Form 483 observations following the inspection. According to the company, all the observations are procedural and minor in nature. Havix is committed to addressing the points raised and will submit its response to the USFDA within the stipulated 15-day period. In the exchnge filings, the company shared, 'We hereby inform that Havix Group Inc. D/B/A Aavis Pharmaceuticals ('Havix'), a Material Subsidiary of the Company situated at 9488 Jackson Trail Road, Hoschton, Georgia 30548, USA has completed the United States Food & Drug Administration ('USFDA') inspection of its manufacturing facility from July 21, 2025 to July 25, 2025 with 3 (Three), 483 observations.' This development reaffirms Senores Pharma's ongoing commitment to maintaining global quality standards at its facilities. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at